ATE317400T1 - Herstellung von antikörpern in mammarsekreten von zuchttieren - Google Patents

Herstellung von antikörpern in mammarsekreten von zuchttieren

Info

Publication number
ATE317400T1
ATE317400T1 AT00980089T AT00980089T ATE317400T1 AT E317400 T1 ATE317400 T1 AT E317400T1 AT 00980089 T AT00980089 T AT 00980089T AT 00980089 T AT00980089 T AT 00980089T AT E317400 T1 ATE317400 T1 AT E317400T1
Authority
AT
Austria
Prior art keywords
mammar
secrets
antibodies
production
animal
Prior art date
Application number
AT00980089T
Other languages
English (en)
Inventor
Sang He Lee
Original Assignee
Mucovax Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucovax Holding B V filed Critical Mucovax Holding B V
Application granted granted Critical
Publication of ATE317400T1 publication Critical patent/ATE317400T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00980089T 1999-11-01 2000-10-31 Herstellung von antikörpern in mammarsekreten von zuchttieren ATE317400T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16275299P 1999-11-01 1999-11-01
EP00202709 2000-07-27

Publications (1)

Publication Number Publication Date
ATE317400T1 true ATE317400T1 (de) 2006-02-15

Family

ID=26072559

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00980089T ATE317400T1 (de) 1999-11-01 2000-10-31 Herstellung von antikörpern in mammarsekreten von zuchttieren

Country Status (14)

Country Link
EP (1) EP1226176B1 (de)
JP (1) JP4668499B2 (de)
KR (1) KR100627635B1 (de)
AT (1) ATE317400T1 (de)
AU (1) AU779776B2 (de)
CA (1) CA2389582C (de)
CY (1) CY1105024T1 (de)
DE (1) DE60025945T2 (de)
DK (1) DK1226176T3 (de)
ES (1) ES2258483T3 (de)
HK (1) HK1048323B (de)
NZ (1) NZ518638A (de)
PT (1) PT1226176E (de)
WO (1) WO2001032713A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1806970A4 (de) * 2004-10-06 2011-06-29 Agri Biotech Pty Ltd Milchproduktionsverfahren
JP2008515813A (ja) * 2004-10-06 2008-05-15 アグリ−バイオテック ピーティーワイ リミテッド 抗体産生方法
AU2005291856B2 (en) * 2004-10-06 2011-05-12 Agri-Biotech Pty Ltd Antibody production method
BRPI0906060A2 (pt) 2008-02-28 2015-12-01 3M Innovative Properties Co anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
JPH0892108A (ja) * 1994-09-19 1996-04-09 Mitsubishi Chem Corp ヒトロタウイルス下痢症に対する予防および治療薬
JPH11510793A (ja) * 1995-07-07 1999-09-21 オラバックス インク． 胃腸病に対する鼻腔内ワクチン接種
US6616927B2 (en) * 1997-05-29 2003-09-09 Agresearch Limited Processes for production of immunoglobulin A in milk

Also Published As

Publication number Publication date
DE60025945T2 (de) 2006-09-28
JP4668499B2 (ja) 2011-04-13
EP1226176A1 (de) 2002-07-31
CY1105024T1 (el) 2010-03-03
CA2389582C (en) 2010-08-31
AU1739001A (en) 2001-05-14
WO2001032713A1 (en) 2001-05-10
CA2389582A1 (en) 2001-05-10
KR100627635B1 (ko) 2006-09-25
PT1226176E (pt) 2006-06-30
EP1226176B1 (de) 2006-02-08
ES2258483T3 (es) 2006-09-01
DK1226176T3 (da) 2006-06-06
HK1048323B (en) 2006-04-28
JP2003513106A (ja) 2003-04-08
NZ518638A (en) 2003-10-31
DE60025945D1 (de) 2006-04-20
AU779776B2 (en) 2005-02-10
HK1048323A1 (en) 2003-03-28
KR20020065497A (ko) 2002-08-13

Similar Documents

Publication Publication Date Title
ATE200679T1 (de) Neues verfahren zur herstellung von anti-humanen antigenrezeptoren und deren verwendungen
BG44538A3 (bg) Метод за получаване на соли на 5-метокси-2-голяма скоба(4 метокси- 3,5-диметил-2-пиридинил)-метил сулфонил голяма скоба-1н-бензимидазол
BR9809656A (pt) Composição imunopotencializante
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
WO2005037190A3 (en) Multiplex vaccines
ATE287947T1 (de) Orale immunisierung durch verwendung von transgenen pflanzen
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ATE317267T1 (de) Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
MY133377A (en) Anti-il-12 antibodies, compositions, methods and uses
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
FI972431A7 (fi) Sytotoksisten T-lymfosyyttivasteiden induktio
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
FI830897L (fi) Foerfarande foer framstaellning av nya konjugat, vari enzym och antikropp aer bundna vid varandra medelst en kovalent bindning
TR199800607T1 (xx) Dendritik h�cre uyar�c� fakt�r�.
IL161832A0 (en) Pharmaceutical composition for inducing an immune response in a human or animal
IS4922A (is) Fjölpeptíð sem geta myndað formgerðir mótefnisvakabindinga með sérvirkni fyrir resus D mótefnisvaka, DNA-ið sem táknar þau og aðferðin til að búa þautil og notkun
ATE317400T1 (de) Herstellung von antikörpern in mammarsekreten von zuchttieren
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
SE8101884L (sv) Farmaceutiska preparat
IT8323383A0 (it) Procedimento per la realizzazione di pannelli per l'ottenimento di mobili e simili, nonche' macchina automatica per la sua attuazione.
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
NO20014772D0 (no) Fremgangsmåter for forhindring eller attenuering av patoangiogene tilstander
ATE237639T1 (de) Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1226176

Country of ref document: EP